NanoViricides Inc (NYSEAMERICAN:NNVC) was the recipient of a significant drop in short interest in December. As of December 29th, there was short interest totalling 459,345 shares, a drop of 44.7% from the December 15th total of 830,252 shares. Approximately 0.9% of the company’s stock are short sold. Based on an average trading volume of 186,490 shares, the days-to-cover ratio is currently 2.5 days.
Shares of NanoViricides (NYSEAMERICAN:NNVC) opened at $0.90 on Friday. NanoViricides has a 12-month low of $0.83 and a 12-month high of $1.64. The company has a market capitalization of $57.00, a price-to-earnings ratio of -6.00 and a beta of 0.21.
NanoViricides (NYSEAMERICAN:NNVC) last released its quarterly earnings data on Tuesday, November 14th. The company reported ($0.03) EPS for the quarter.
Separately, BidaskClub downgraded NanoViricides from a “sell” rating to a “strong sell” rating in a report on Saturday, November 4th.
NanoViricides Company Profile
NanoViricides, Inc is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the issues of viral diseases.
Receive News & Ratings for NanoViricides Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoViricides and related companies with MarketBeat.com's FREE daily email newsletter.